Already A Hit In NYC, Neko Health’s Body Scan Clinic Plots Nationwide Expansion

TL;DR

Before you orderOffer from Amazon

Get oils, diffusers and self-care delivered free with Prime

• Fast, free delivery on millions of items
• Prime Video, Amazon Music and more included
• Member-only deals all year

Start your free Prime trial →Free trial for eligible customers · Cancel anytime

As an affiliate, we earn on qualifying purchases.Hide

Neko Health says its waitlist for its first U.S. clinic has topped 50,000 and that it plans new locations in Manhattan, Miami, San Francisco and Washington, D.C. The $499 scan combines skin imaging, measurements and bloodwork, but does not image internal organs or diagnose many diseases.

Neko Health says it plans to expand beyond its first U.S. clinic in New York, with a second Manhattan location planned for January and a Miami clinic due by the end of the year. The company, co-founded by Spotify founder Daniel Ek, says its New York waitlist has grown to more than 50,000, while San Francisco and Washington, D.C., are also in its expansion pipeline.

The company’s first U.S. clinic opened in SoHo last month, according to Athletech News. More than 25,000 New Yorkers had joined its waitlist before opening; Neko says the list more than doubled to over 50,000 in the following two weeks. The company has not released figures showing how many people on the list have booked or completed a scan.

Neko charges $499 for a noninvasive scan that combines visible-light cameras, infrared thermal imaging and depth sensing to map skin and flag moles for closer review. A visit also includes blood pressure and body-composition checks, an EKG and other cardiac measurements, grip strength and eye-pressure tests, and a blood panel covering 53 biomarkers. The company says the appointment and clinician review take about an hour.

Neko announced a $700 million Series C led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with other investors including Mark Zuckerberg, the report said. The source does not give opening dates for San Francisco or Washington, D.C. The immediate schedule it reports is a second Manhattan clinic in January and a Miami location before year-end.

A New Model for Preventive Scans

The expansion would make Neko’s paid screening model available beyond SoHo, where the company says demand has exceeded 50,000 waitlist sign-ups. For consumers, the proposition is a bundled appointment: measurements, blood tests and a clinician discussion in one visit for $499. That may appeal to people seeking health information outside a traditional appointment, but it does not make the service a substitute for routine medical care or diagnostic testing.

The report places Neko’s launch amid wider consumer interest in wellness and dissatisfaction with health-care affordability. It cites a Gallup poll in which 24% of Americans rated U.S. health-care coverage excellent or good in December 2025, and a West Health-Gallup index finding that 49% of adults could consistently afford care in 2025. Those figures provide market context; they do not establish why people joined Neko’s list or prove that the clinic’s approach improves health outcomes.

Other businesses are also selling tests and health services to consumers, including Life Time’s Miora clinics and wearable-linked blood testing. Neko’s proposed distinction is combining several checks and a clinician review in one location. Whether that package can attract repeat customers and operate across multiple cities remains to be seen.

What the $499 Scan Covers

Neko was co-founded by Daniel Ek and CEO Hjalmar Nilsonne. Its scan focuses on cardiometabolic health and skin cancer-related findings, using cameras and sensors alongside blood tests and physical measurements. Members can review results with a clinician and access them through Neko’s app, which the company says can also connect to data from wearables such as Oura and Whoop through Apple Health.

The limits are material. Neko says the scan is not an MRI or CT scan and does not produce images of internal organs. It does not screen for breast, colon, lung, prostate or most other cancers. Although it can flag signs associated with coronary artery disease, Neko says it cannot diagnose or rule out that condition. The report distinguishes this approach from Prenuvo’s whole-body MRI scans.

Neko says members who need follow-up can be referred to partner providers in New York, including Columbia University Irving Medical Center, Mount Sinai Health System and Schweiger Dermatology, or can see their own doctors. The company accepts HSA and FSA payments, according to the report. In Sweden and the U.K., where Neko says it has scanned more than 100,000 people, the company reports that 75% book and prepay for another scan before leaving, and 80% book a third after their second. It has not shared equivalent U.S. rebooking figures.

“What we’ve seen is unmistakable: when people can see their health clearly and know what to do about it, they get healthier.”

— Hjalmar Nilsonne, Neko Health co-founder and CEO, speaking when the New York clinic opened

Expansion Dates and U.S. Demand

Several details remain unreported. Neko has not provided exact opening dates for the San Francisco and Washington, D.C., clinics, nor has it said how many locations it ultimately intends to open nationwide. The report gives no U.S. booking, completed-scan or repeat-visit figures, so the 50,000-plus waitlist should not be read as a count of paying customers.

The available information also does not establish whether the planned clinics have secured all required sites or approvals, or whether the schedule could change. Neko’s statements about the scan’s scope and repeat bookings come from the company; the source material does not provide independent evaluation of the service’s clinical performance or health outcomes.

The Next Clinic Openings

The next reported milestone is a second Manhattan clinic at Brookfield Place in January, followed by the Miami location, which the company plans to open by the end of the year. Neko has also identified San Francisco and Washington, D.C., as locations in its pipeline, without giving dates.

Further updates will show whether the company meets those timelines and whether interest in New York translates into appointments and repeat visits. Until it releases U.S. operating figures, the size of the waitlist offers a measure of stated interest, not evidence of completed scans or clinical impact.

Key Questions

Where is Neko Health expanding in the United States?

Neko plans a second Manhattan clinic at Brookfield Place and a Miami location. San Francisco and Washington, D.C., are also in the company’s pipeline, but dates for those cities have not been reported.

How much does a Neko Health scan cost?

The scan costs $499, according to the source report. Neko also accepts HSA and FSA payments, the report says.

What does the scan test for?

The visit includes skin imaging and checks including blood pressure, body composition, an EKG, other cardiac measurements, grip strength and eye pressure, plus a 53-biomarker blood panel. Neko says the service focuses on cardiometabolic health and skin cancer-related findings.

Does the scan detect cancer or replace a doctor’s care?

Neko says it does not image internal organs and does not screen for breast, colon, lung, prostate or most other cancers. It also says it cannot diagnose or rule out coronary artery disease. The company describes follow-up through partner providers or a customer’s own doctor; the scan is not presented as a replacement for medical care.

How many people have joined the New York waitlist?

Neko says the list grew to more than 50,000 after its SoHo clinic opened. The company has not reported how many people on the list have booked or completed a scan in the United States.

Source: rss